ProfileGDS5678 / 1443211_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 5% 5% 5% 5% 5% 5% 5% 5% 5% 5% 5% 5% 5% 5% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.098775
GSM967853U87-EV human glioblastoma xenograft - Control 22.08285
GSM967854U87-EV human glioblastoma xenograft - Control 32.084095
GSM967855U87-EV human glioblastoma xenograft - Control 42.032415
GSM967856U87-EV human glioblastoma xenograft - Control 52.027365
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.124985
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.090125
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.06025
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.052635
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.070395
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.067945
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.055385
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.073345
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.070975